(Q82610716)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

α-Galactosylceramide activates antitumor immunity against liver tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

α‐Galactosylceramide activates antitumor immunity against liver tumor (English)

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

3 September 2024

author name string

Tomohide Tatsumi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tetsuo Takehara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Takuya Miyagi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tsukasa Sugiyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hiroshi Aketa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Akira Sasakawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tatsuya Kanto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Naoki Hiramatsu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Norio Hayashi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21108702

3 September 2024

publication date

25 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 January 2020

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1872-034X.2010.00743.x

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1872-034X.2010.00743.x

3 September 2024

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

3 September 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

160-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

17 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

3 September 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

3 September 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver

3 September 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Innate and adaptive lymphoid cells in the human liver

3 September 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Immunology of the healthy liver: old questions and new insights

3 September 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

The dendritic cell system and its role in immunogenicity

3 September 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

3 September 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Reciprocal activating interaction between natural killer cells and dendritic cells

3 September 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

3 September 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

3 September 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity

3 September 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

3 September 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

3 September 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Activated liver dendritic cells generate strong acquired immunity in alpha-galactosylceramide treatment

3 September 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

3 September 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Natural killer cell is a major producer of interferon gamma that is critical for the IL-12-induced anti-tumor effect in mice

3 September 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines

3 September 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

NK cell compartments and their activation by dendritic cells

3 September 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma

3 September 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas

3 September 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

3 September 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Regulation of human cytolytic lymphocyte responses by interleukin-12

3 September 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12

3 September 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

3 September 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

3 September 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

3 September 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes

3 September 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1872-034X.2010.00743.X

3 September 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21108702%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference